P-198: Real-life experience of the combination of daratumumab, bortezomib, melphalan, and prednisone (DVMP) in patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplantation
Title:
P-198: Real-life experience of the combination of daratumumab, bortezomib, melphalan, and prednisone (DVMP) in patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplantation
Author:
Domingo-González, Amalia Alonso, Rafael de Soto Álvarez, Teresa Lerma, Ana Moro, Fernando Martín Sánchez-Pina, Jose Fernández, Virginia Pradillo Landete, Elena Valdazo, Alberto E. Velasco Cuevas, Marina Menéndez Riñón, Mónica María López López, Andrés Ramírez López-García, Alberto del Campo, Paula Lázaro Gómez, Fabio Augusto Ruiz Blanchard, María Jesús Askari, Elham